Vimian Group AB (publ) (OTCMKTS:VIMGF) Short Interest Up 164.2% in March

Vimian Group AB (publ) (OTCMKTS:VIMGF) saw a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 460,800 shares, a growth of 164.2% from the February 28th total of 174,400 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

Vimian Group AB (publ) Stock Performance

OTCMKTS VIMGF remained flat at C$3.50 on Friday. Vimian Group AB has a 12-month low of C$2.68 and a 12-month high of C$4.12. The business has a 50 day moving average of C$3.50 and a two-hundred day moving average of C$3.68.

About Vimian Group AB (publ)

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.